Cookies help us deliver our services. By using our services, you agree to our use of cookies.
Learn more
OK
Skip to main content (Press Enter).
Sign In
Skip auxiliary navigation (Press Enter).
Contact Us
Skip main navigation (Press Enter).
Toggle navigation
Search Options
About
What is the AMS
AMS International Scientific Committee
AMS North America Scientific Committee
AMS Educational Executive Committee
AMS Ambassadors
Certifications and Educational Credits
Upcoming Events
Videos & Webinars
International Events
Become a Speaker
Videos On Demand
Education 365
Preview AMS TV
Features
AMS Features
News & Publications
AMS Bookstore
Blogs
Industry
Industry Partners
Become a Sponsor
Features
Blogs
Blog Viewer
Blogs
The therapeutic effects of blocking IGF-R1 on mice model of skin cancer
By
- AMS
posted
Jan 04, 2020 04:58 AM
0
Recommend
Volume 32, Issue 7
, November 2021, Page 803-811
.
0 comments
0 views
Permalink
Related Content
Anti-TNF agent etanercept augments UV-induced skin cancer development in SKH-1 mice
- AMS
Added Jan 07, 2020
Blog Entry
Vitamin D deficiency and hidradenitis suppurativa: the impact on clinical severity and therapeutic responsivity
- AMS
Added Jan 29, 2020
Blog Entry
Comparing the effects of proactive treatment with tacrolimus ointment and mometasone furoate on the epidermal barrier structure and ceramide levels of patients with atopic dermatitis
- AMS
Added Jan 04, 2020
Blog Entry
Liraglutide improved inflammation via mediating IL-23/Th-17 pathway in obese diabetic mice with psoriasiform skin
- AMS
Added Jan 04, 2020
Blog Entry
Emerging novel therapeutic agents for the treatment of patients with prurigo nodularis
- AMS
Added Jan 04, 2020
Blog Entry
© 2022 AMS, Aesthetic Multispecialty Society. All Rights Reserved.
Powered by Higher Logic